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INTRODUCTION: Endothelium-dependent dilation is improved in insulin-treated diabetic patients, but this effect is
probably due to improved glycemic control. The objective of the present study was to compare endothelium-
dependent dilation in patients with well-controlled type 2 diabetes who are or are not using insulin as part of their
therapy.
METHODS: We studied 27 patients with type 2 diabetes (11 women, 60.3 years ¡ 6 years, with HbA1c , 7% and no
nephropathy), including 16 patients treated with anti-diabetic agents (No-Ins, 8 women) and 11 patients treated
with insulin alone or in combination with anti-diabetic agents (Ins, 3 women). Endothelial function was evaluated
by the dorsal hand vein technique, which measures changes in vein diameter in response to phenylephrine,
acetylcholine (endothelium-dependent vasodilation) and sodium nitroprusside (endothelium-independent vasodi-
lation).
RESULTS: Age, systolic blood pressure (No-Ins: 129.4 mmHg ¡ 11.8 mmHg, Ins: 134.8 mmHg ¡ 12.0 mmHg; P=
0.257), HbA1c, lipids and urinary albumin excretion rate [No-Ins: 9 mg/24 h (0-14.1 mg/24h )vs. Ins: 10.6 mg/24 h (7.5-
14.4 mg/24 h), P=0.398] were similar between groups. There was no difference between endothelium-dependent
vasodilation of the No-Ins group (59.3% ¡ 26.5%) vs. the Ins group (54.0% ¡ 16.3%; P=0.526). Endothelium-
independent vasodilation was also similar between the No-Ins (113.7% ¡ 35.3%) and Ins groups (111.9% ¡ 28.5%;
P=0.888).
CONCLUSIONS: Subcutaneous insulin therapy does not interfere with venous endothelial function in type 2 diabetes
when glycemic and blood pressure control are stable.
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INTRODUCTION
The high cardiovascular risk posed by diabetes mellitus
(DM) can be attributed to both classic risk factors
1 and also
to hyperglycemia and its consequences: oxidative stress and
endothelial dysfunction.
2,3 These abnormalities are related
to insulin resistance, which is detrimental to endothelial
function and leads to a pro-inflammatory and pro-coagulant
state that plays an important role in mediating atherogen-
esis and cardiovascular disease.
4 Diabetes mellitus
2 and
hyperglycemia
5 are independent determinants of endothe-
lial dysfunction.
Short-term improvement of glucose control in diabetic
patients cannot reverse endothelial dysfunction,
6,7 but long-
term treatment of diabetes may be able to achieve this
goal.
8,9 It is not known if the treatment of diabetic patients
with subcutaneous insulin can interfere with the evaluation
of endothelial function. No existing studies have evaluated
the possible effect of subcutaneous insulin use on venous
endothelial function, a method that, in some instances, can
be more sensitive to subtle endothelial abnormalities.
10 The
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1139aim of this study was to compare endothelium-dependent
dilation in patients with type 2 DM with good metabolic
and blood pressure control according to whether they used
insulin as part of their therapy.
METHODS
Patients
We studied 27 patients with type 2 diabetes (11 women;
age at diagnosis . 35 years old, no previous history of
ketoacidosis, insulin independence for at least 12 months
after diagnosis), including 16 patients treated with diet
alone and/or anti-diabetic agents (No-Ins group) and 11
patients treated with subcutaneous insulin (NPH and/or
regular insulin; 38.2 ¡ 11.6 U/patient) with or without anti-
diabetic agents (Ins group). Patients were selected from
the outpatients visiting the internal medicine ward of
Irmandade Santa Casa de Miserico ´rdia de Porto Alegre
(ISCMPA) or Hospital de Clı ´nicas de Porto Alegre (HCPA).
We excluded patients older than 70 years and those patients
with high blood pressure levels (systolic arterial pressure .
180 mmHg and/or diastolic . 100 mmHg); microalbumi-
nuria (24 h urinary albumin . 30 mg/24 h); creatinine .
1.2 mg/dL; body mass index . 30 kg/m
2; acute coronary
syndromes; stable angina; current smokers; those patients
under treatment with nitrates or alpha-receptor antagonists;
and/or those patients who were unable to understand and
sign the consent form. The recommended carbohydrate
consumption was limited to 60% of the total caloric intake
for all patients.
Protocol
The protocol was approved by the Research Unit Ethics
Committees at Hospital de Clı ´nicas de Porto Alegre
(HCPA), Universidade Federal de Cie ˆncias da Sau ´de de
Porto Alegre (UFCSPA) and Irmandade Santa Casa de
Miserico ´rdia de Porto Alegre (ISCMPA), and informed
consent was obtained from each patient. All subjects were
instructed to avoid caffeinated drinks and alcohol for the 12-
h period preceding their appointment. The studies started
about 3 h after the participant consumed a light breakfast.
Dorsal hand vein technique
Venous endothelial function evaluation was performed in
a quiet room at a constant temperature of 21˚C ¡ 1˚C.
Venous endothelial function was assessed in all patients via
the dorsal hand vein technique,
11 a method for which our
group has published details elsewhere.
10,12,13 Briefly, a 23-
gauge butterfly needle was inserted into a suitable vein on
the back of the hand, and a continuous infusion of
physiologic saline solution (0.3 mL/min) was started. A
tripod holding a linear variable differential transformer
(LVDT; Shaevitz Engineering, Pennsauken, NJ) was
mounted on the hand, with the central aperture of the
LVDT that contained a movable metallic core located 10 mm
downstream from the tip of the needle. The signal output of
the LVDT, which is linearly proportional to the vertical
movement of the core, provided a measurement of the vein
diameter. Readings were taken at a congestive pressure of
40 mmHg by inflating a blood pressure cuff placed on the
upper portion of the arm being studied. The vein was pre-
constricted by infusing increasing doses of the a1-adrener-
gic selective agonist phenylephrine (25 ng/min to 8333,3 ng/
min) until the dose that produced approximately 70%
constriction of the vein was found (ED70). This degree of
pre-constriction was defined as 0% venodilation. The
endothelium-dependent venodilation was assessed with
incremental infusions of acetylcholine (3.6 ng/min to
3600 ng/min), and endothelium-independent venodilation
with sodium nitroprusside (495.3 ng/min to 990.6 ng/min)
was calculated as a percentage of the range between 100%
and 0% vasodilation. Drugs were infused with a Harvard
infusion pump (Harvard Apparatus Inc., South Natick,
MA). Blood pressure and heart rate were monitored in the
contra-lateral arm with a sphygmomanometer.
Biochemical measurements
Venous blood and urine samples were obtained during
the morning hours after an overnight fast. Albuminuria was
determined by immunoturbidimetry (MicroAlb; Ames-
Bayer, Tarrytown, NY, USA); plasma glucose was deter-
mined by the glucose-peroxidase colorimetric enzymatic
method (Biodiagnostica, Pinhais, Brazil); and total choles-
terol, HDL cholesterol and triglycerides were determined by
a colorimetric method and HbA1c by high-performance
liquid chromatography (Merck-Hitachi L-9100; Merck,
Darmstadt, Germany). LDL cholesterol was calculated
according to the Friedwald formula. Serum creatinine was
measured by the Jaffe ´ method. Serum insulin was deter-
mined by enzyme immunoassay commercial kits (Abbot-
Murex, Park, IL, USA,), and high-sensitivity C-reactive
protein (CRP) was measured by nephelometry.
Statistical analyses
Analyses were performed using SPSSH Base 13.0 (SPSS
Inc., Chicago, IL, USA). The results are presented as the
means ¡ standard deviations (SD) or medians (25th-75th
percentile). Variables that did not have a Gaussian
distribution (Kolmogorov-Smirnov test) were log10-trans-
formed before additional analyses. Differences between the
groups were tested with unpaired Student’s t-tests and chi-
square tests. The differences were recognized as statistically
significant when P , 0.05.
RESULTS
No differences were observed between the groups
studied concerning age (P=0.470), body mass index
(P=0.224) or duration of diabetes (P=0.142). These and
other clinical and laboratory data are shown in Table 1.
There were no differences between the groups concerning
these characteristics.
Among the 16 patients of the No-Ins group, 10 patients
used statins, 10 patients used aspirin, 10 patients used
diuretics, 13 patients used angiotensin-converting enzyme
inhibitors, 12 patients used metformin, 4 patients used
sulfonylurea, and 5 patients used beta-blockers. Among the
11 patients of the Ins group, 5 patients used statins, 6
patients used aspirin, 6 patients used angiotensin-convert-
ing enzyme inhibitors, 6 patients used metformin, 2 patients
used sulfonylurea, 4 patients used diuretics, and 5 patients
used beta-blockers.
Venous endothelial function data are shown in Table 2.
Endothelium-dependent venodilation (P=0.526) as mea-
sured for maximum venodilation by acetylcholine, veno-
constriction induced by phenylephrine (P=0.566) and
venodilation by sodium nitroprusside (endothelium-inde-
pendent venodilation; P=0.888) were similar between
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doses of acetylcholine and sodium nitroprusside needed to
reach maximum venodilation were not different between
the No-Ins and Ins groups. The diameter of the dorsal hand
vein did not differ (P=0.942) between the No-Ins group
(1.2 mm ¡ 0.7 mm) and Ins group (1.3 mm ¡ 0.6 mm).
DISCUSSION
The results of the present study show for the first time
that venous endothelial function is similar among type 2
diabetic patients with good metabolic control and well-
controlled blood pressure levels, irrespective of their
treatment with subcutaneous insulin.
Insulin has known physiological effects upon the vascu-
lature, although the results of studies concerning these
effects are discordant. Vasoconstriction and high vascular
tonus have been described by some authors,
14,15 while other
authors have demonstrated vasodilation induced by insulin
infusion.
16,17 Perhaps these results are discordant because
data were obtained from different vascular beds and from
different species. In rabbit kidneys, insulin induced afferent
arteriolar vasodilation, with no effects upon the efferent
artery.
18 In diabetic patients, both regular and lispro insulin
promoted the improvement of arterial endothelial function
after a meal.
19,20 Short-term glucose control obtained with
insulin and metformin
9 or with insulin only
8 can also induce
better arterial endothelial function when compared with the
same evaluation performed in hyperglycemic diabetic
patients.
Thepresentstudywasperformedintype2diabeticpatients
with good metabolic control, as confirmed by their fasting
plasma glucose levels and HbA1c. Their blood pressure levels
were also very well controlled. Both hyperglycemia
21 and
high blood pressure levels
22 can interfere with endothelial-
dependent vasodilation. Although these factors were under
control, there was still venous endothelial dysfunction in all
of the patients in the group as compared to non-diabetic
subjects, who showed 105.8% ¡ 9.5% of endothelium-
dependent vasodilation in a previous study carried out by
our group.
10 There were no differences between the groups
studied except for the use of insulin, indicating that the
subcutaneous use of insulin does not interfere with venous
endothelial function, as was previously shown for arterial
endothelium evaluation.
23
Some limitations of this study should be mentioned, such
as the small sample size in the Ins group. This group was
not easy to recruit due to the necessary characteristics of the
patients (i.e., very good glycemic and arterial pressure
control). Additionally, because microcirculatory dysfunc-
tion is already present in subjects with metabolic syndrome
without diabetes and is associated with the adiposity of
these individuals, the characteristic inflammatory state of
obesity may cause this abnormality; however, insulin
resistance and hyperinsulinemia cannot be discarded as
possible causes.
24 Although good reproducibility of venous
and arterial endothelial function evaluation was previously
shown,
25 arteries and veins have different biological
activities in terms of the endothelium, probably due to
marked regional and segmental heterogeneity in vascular
endothelial function.
26 Future studies investigating the
association between different vascular beds in response to
subcutaneous insulin therapy may introduce new knowl-
edge in this field of investigation.
The present data allow us to conclude that patients with
type 2 diabetes treated with diet and anti-diabetic agents
have similar venous endothelial function to those patients
treated additionally with subcutaneous insulin. Subcu-
taneous insulin therapy does not interfere with venous
endothelial function in type 2 diabetes given stable glycemic
and blood pressure control.
Table 1 - Baseline clinical and laboratory characteristics by
group.
No-Ins (n=16) Ins (n=11) P
Male (n, %) 8 (50) 8 (72.7) 0.441
Age (years) 59.6 ¡ 4.8 61.3 ¡ 6.6 0.470
Weight (kg) 68.3 ¡ 10.3 69.0 ¡ 15.5 0.906
BMI (kg/m
2)2 6 . 8 ¡ 1.9 25.2 ¡ 4.0 0.224
Systolic BP (mmHg) 129.4 ¡ 11.8 134.8 ¡ 12.0 0.257
Diastolic BP (mmHg) 81.3 ¡ 5.3 80.9 ¡ 4.9 0.866
Heart rate (bpm) 69.0 ¡ 8.9 71.5 ¡ 4.8 0.363
Diabetes duration (years) 6.8 ¡ 2.5 8.4 ¡ 5.5 0.142
24-h albuminuria (mg)* 9 (0-14.1) 10.6 (7,5-14,4) 0.398
Total cholesterol (mg/dL) 161.1 ¡ 33.6 157.2 ¡ 18.1 0.715
HDL cholesterol (mg/dL) 46.9 ¡ 9.3 49.1 ¡ 11.7 0.622
LDL cholesterol (mg/dL) 82.8 ¡ 37.3 75.7 ¡ 30.8 0.601
Triglycerides
(mg/dL)
115 (92.3-167) 126 (112.5-140.8) 0.835
Plasma glucose (mg/dL) 124.7 ¡ 17.6 130.7 ¡ 11.6 0.326
HbA1c (%) 6.6 ¡ 0.6 6.9 ¡ 0.9 0.317
Insulinemia (mU/mL) 9.9 ¡ 4.3 10.8 ¡ 3.3 0.561
CRP (mg/L) 2.3 ¡ 0.8 2.1 ¡ 1.0 0.704
Creatinine (mg/dL) 0.9 ¡ 0.2 0.9 ¡ 0.1 0.729
Data are means ¡ SDs, medians (25th-75th percentile) or n (%); BMI: body
mass index; BP: blood pressure; HbA1c: glycated hemoglobin; CRP:
C-reactive protein; *values before log transformation (log10). No-Ins:
diabetic patients treated with diet and/or anti-diabetic agents; Ins:
diabetic patients treated with diet and insulin, with or without anti-
diabetic agents; Pearson chi-squared test or unpaired Student’s t-test.
Table 2 - Venous endothelial function by group.
Parameter No-Ins Ins P
Venoconstriction (%, phenylephrine) 74.5 ¡ 8.3 72.5 ¡ 9.2 0.566
Emax (%, acetylcholine) 59.3 ¡ 26.5 54.0 ¡ 16.3 0.526
Emax (%, sodium nitroprusside) 113.7 ¡ 35.3 111.9 ¡ 28.5 0.888
Drug concentrations
ED70 (ng/min, phenylephrine) 50 (25-100) 100 (25-100) 0.893
Emax (ng/min, acetylcholine) 3600 (630-3600) 3600 (1800-3600) 0.874
Emax (ng/min, sodium nitroprusside) 371.5 (247.7-495.3) 247.7 (247.7-495.3) 0.501
Data are means ¡ SDs or medians (25th-75th percentile). Emax: maximum effect; ED70: dose that produced approximately 70% constriction of the vein.
Values of drug concentrations are given before log10 transformation.
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